TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy
TP53缺失与接受CHOP方案化疗的ALK阳性成人间变性大细胞淋巴瘤（ALCL）患者预后不良相关。
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-025-06297-y
Katagiri, Seiichiro; Akahane, Daigo; Takeyama, Kunihiko; Sato, Norihide; Takayama, Nobuyuki; Ando, Jun; Nitta, Hideaki; Noguchi, Masaaki; Naganuma, Ken; Momose, Shuji; Tabayashi, Takayuki; Kizaki, Masahiro; Kawada, Hiroshi; Kikuti, Yara Yukie; Carreras, Joaquim; Nakamura, Naoya; Gotoh, Akihiko
